Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area dna damage atm kinase'

Search results for: 'research area dna damage atm kinase'

Items 121-130 of 278

Page
per page
  1. Tofacitinib (CP-690550,Tasocitinib)
    A4138 Tofacitinib (CP-690550,Tasocitinib)
     1 Citation
    Target: JAK
    Summary: Janus kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥15.6 mg/mL
  2. NH125
    A8814 NH125
     1 Citation
    Target: eEF-2
    Summary: Selective eEF-2 kinase inhibitor
      ≥25.9 mg/mL
  3. LKB1 (AAK1 dual inhibitor)
    A3556 LKB1 (AAK1 dual inhibitor)
    Target: Pim
    Summary: Pim-1 kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥34.8 mg/mL
  4. ABC294640
    B1182 ABC294640
    Target: SK
    Summary: Sphingosine kinase 2 inhibitor,selective and competitive
      ≥38.1 mg/mL
  5. TBB
    A3861 TBB
     1 Citation
    Target: CK2
    Summary: Casein kinase-2 (CK2) inhibitor
      insoluble in H2O; ≥159.2 mg/mL
  6. LDC1267
    B4893 LDC1267
    Target: TAM kinase
    Summary: TAM kinase inhibitor,highly selective
      insoluble in H2O; insoluble in EtOH; ≥20.75 mg/mL
  7. SR-3677
    B1294 SR-3677
    Target: ROCK
    Summary: Rho Kinase (ROCK-II) inhibitor
      Soluble in DMSO
  8. Radotinib(IY-5511)
    B5846 Radotinib(IY-5511)
    Target: PDGFR|Bcr-Abl
    Summary: Bcr-Abl tyrosine kinase inhibitor
      ≥13.73 mg/mL
  9. BLZ945
    B4899 BLZ945
     1 Citation
    Target: CSF-1R
    Summary: CSF-1R kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.9 mg/mL
  10. PLX-4720
    A3016 PLX-4720
     1 Citation
    Target: Raf
    Summary: BRAF kinase inhibitor
      ≥20.69 mg/mL

Items 121-130 of 278

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 274item
  2. Natural Products 1 item
  3. Peptides 1 item
  4. Peptides & Proteins 1 item
Reversibility
  1. Reversible 21item
  2. Irreversible 5item
Target
  1. Cyclin-Dependent Kinases 21item
  2. Akt 2item
  3. PI3K 14item
  4. Raf 7item
  5. Aurora Kinases 13item
  6. CSF-1R 2item
  7. mTOR 8item
  8. AP-1 1 item
  9. FLT3 8item
  10. GSK-3 7item
  11. PLK 4item
  12. Chk 5item
  13. Eph Receptors 3item
  14. VEGFR 19item
  15. PDGFR 14item
  16. c-Kit 6item
  17. RET 3item
  18. IRAK 2item
  19. Bromodomain-containing proteins(BRDs) 1 item
  20. Thymidylate Synthase 1 item
  21. p38 6item
  22. PKB 1 item
  23. JNK 2item
  24. SGK 2item
  25. Bcr-Abl 10item
  26. MEK 4item
  27. FGFR 6item
  28. Pim 4item
  29. Ribosomal s6 kinases (RSK) 1 item
  30. MET 5item
  31. Src 8item
  32. Trk Receptors 3item
  33. STAT 3item
  34. EGFR 10item
  35. ROCK 6item
  36. BTK 1 item
  37. PAK 3item
  38. FAK 4item
  39. BMP and Other Activin Receptors 2item
  40. JAK 9item
  41. Syk 5item
  42. DNA-PK 6item
  43. AMPK 2item
  44. PDHK 1 item
  45. Topoisomerases 5item
  46. ErbB 2item
  47. S6 kinases 1 item
  48. Adenosine Kinases 2item
  49. DNA Methyltransferases 3item
  50. ERK 2item
  51. c-MET 5item
  52. PKC 5item
  53. Ubiquitin-specific proteases 1 item
  54. Ca2 /calmodulin-dependent protein kinases (CaMKs) 6item
  55. Lyn 1 item
  56. HER2 2item
  57. Pyk2 3item
  58. LRRK2 3item
  59. Insulin and Insulin-like Receptors 2item
  60. ALK 3item
  61. ROS1 1 item
  62. Sphingosine kinases (SphKs) 1 item
  63. PKG 1 item
  64. PKA 1 item
  65. Myosin light chain kinases (MLCKs) 2item
  66. CaM-KK 1 item
  67. MELK 1 item
  68. Insulin-like growth factors (IGFs) 1 item
  69. Clk 1 item
  70. NUAK1 1 item
  71. NUAK2 1 item
  72. MK2 2item
  73. Fatty-acid-binding proteins (FABPs) 1 item
  74. Tie-2 2item
  75. RSK 1 item
  76. ATM/ATR 4item
  77. CK1 1 item
  78. Farnesyl Diphosphate Synthases 1 item
  79. CK2 3item
  80. HIPK2 1 item
  81. HIPK3 1 item
  82. P2X Receptors 1 item
  83. BLM 1 item
  84. HSV 1 item
  85. Synthases/Synthetases 2item
  86. MAGL 1 item
  87. c-Fyn 1 item
  88. TAK1 1 item
  89. P110 1 item
  90. Hck 1 item
  91. RNA Polymerases 1 item
  92. Insulin Receptors 1 item
  93. IRG-1R 1 item
  94. Cdc2-like kinase (Clk) 1 item
  95. eEF-2 1 item
  96. Cdc7 1 item
  97. CMV 1 item
  98. ZAP-70 1 item
  99. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  100. Cytidine deaminases 1 item
  101. c-RET 1 item
  102. p70 rsk 1 item
  103. TAM kinase 1 item
  104. AXL 1 item
  105. c-Fms tyrosine kinase 1 item
  106. STK 1 item
  107. MSK 1 item
  108. Lyn kinase 1 item
  109. ITK 1 item
  110. NUAK 1 item
  111. DCLK2 1 item
  112. Lck 1 item
  113. PKD 1 item
  114. tropomyosin receptor kinase 1 item
  115. SK 1 item
  116. ATM 2item
  117. Sirtuin 1 item
  118. PIKfyve 1 item
  119. Insulin Receptor 1 item
Reported Experiments
  1. Animal Experiments 242item
  2. Cell Experiments 152item
Related Disease
  1. Acute Myelogenous Leukemia 2item
  2. Acute Myeloid Leukemia 16item
  3. Acute Renal Failure 1 item
  4. Adrenocortical Carcinoma 2item
  5. Advanced Renal Cell Carcinoma 1 item
  6. Bladder Cancer 5item
  7. Bladder Carcinoma 2item
  8. Bladder Diseases 1 item
  9. B-lymphoid Malignancies 1 item
  10. Breast Cancer 49item
  11. Cancer 183item
  12. Cervical Cancer 5item
  13. Cholangiocarcinoma 2item
  14. Chronic Lymphocytic Leukemia 2item
  15. Clear Cell Renal Cell Carcinoma 1 item
  16. Colon Cancer 24item
  17. Colon Carcinoma 2item
  18. Colorectal Cancer 22item
  19. Glioblastoma 18item
  20. Glioma 6item
  21. Hepatocellular Carcinoma 5item
  22. HIV Infections 2item
  23. Immunological Diseases 1 item
  24. Inflammatory Bowel Disease 1 item
  25. Inflammatory Diseases 5item
  26. Leukemia 10item
  27. Liver Cancer 3item
  28. Lung Cancer 17item
  29. Lung Carcinoma 3item
  30. Lymphoma 12item
  31. Mantle Cell Lymphoma 1 item
  32. Melanoma 15item
  33. Multiple Myeloma 7item
  34. Myelofibrosis 1 item
  35. Myeloma 2item
  36. Neuroblastoma 3item
  37. Non-small Cell Lung Cancer 5item
  38. Non-small Cell Lung Carcinoma 1 item
  39. Ovarian Cancer 19item
  40. Pancreatic Cancer 24item
  41. Prostate Cancer 21item
  42. Psoriasis 1 item
  43. Pulmonary Arterial Hypertension 1 item
  44. Renal Cancer 3item
  45. Renal Cell Carcinoma 5item
  46. Rheumatoid Arthritis 5item
  47. Sarcoma 1 item
  48. Squamous Cell Carcinoma 1 item
  49. Testicular Cancer 2item
  50. Thyroid Cancer 5item
  51. Type 2 Diabetes 3item